| 2026-05-22 |
详情>>
业绩披露：
2026年年报每股收益-0.02欧元,归母净利润-3.97亿欧元,同比去年增长90.48%
|
| 2026-05-12 |
详情>>
股本变动：
变动后总股本230263.55万股
|
| 2025-11-11 |
详情>>
业绩披露：
2026年中报每股收益0.03欧元,归母净利润8.29亿欧元,同比去年增长-22.09%
|
| 2025-06-06 |
详情>>
业绩披露：
2025年年报每股收益-0.16欧元,归母净利润-41.69亿欧元,同比去年增长-465.7%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年中报每股收益-0.01欧元,归母净利润-3.46亿欧元,同比去年增长-135.09%
|
| 2024-11-12 |
详情>>
业绩披露：
2025年中报每股收益0.04欧元,归母净利润10.64亿欧元,同比去年增长407.51%
|
| 2024-06-14 |
详情>>
业绩披露：
2024年年报每股收益0.04欧元,归母净利润11.40亿欧元,同比去年增长-90.37%
|
| 2024-05-24 |
股东大会：
将于2024-07-30召开股东大会
|
| 2024-05-24 |
股东大会：
将于2024-07-30召开股东大会
|
| 2023-06-21 |
详情>>
业绩披露：
2023年年报每股收益0.43欧元,归母净利润118.38亿欧元,同比去年增长466.95%
|
| 2023-06-21 |
详情>>
业绩披露：
2021年年报每股收益0.00欧元,归母净利润5900.00万欧元,同比去年增长106.41%
|
| 2023-05-26 |
股东大会：
将于2023-07-25召开股东大会
|
| 2023-05-26 |
股东大会：
将于2023-07-25召开股东大会
|
| 2022-11-15 |
详情>>
业绩披露：
2023年中报每股收益0.04欧元,归母净利润9.86亿欧元,同比去年增长-1%
|
| 2022-06-16 |
详情>>
业绩披露：
2020年年报每股收益-0.03欧元,归母净利润-9.2亿欧元,同比去年增长88.53%
|
| 2022-06-16 |
详情>>
业绩披露：
2022年年报每股收益0.07欧元,归母净利润20.88亿欧元,同比去年增长3438.98%
|
| 2022-05-27 |
股东大会：
将于2022-07-26召开股东大会
|
| 2022-05-27 |
股东大会：
将于2022-07-26召开股东大会
|
| 2021-11-23 |
详情>>
业绩披露：
2022年中报每股收益0.03欧元,归母净利润9.96亿欧元,同比去年增长-21.51%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-28 |
股东大会：
将于2021-07-27召开股东大会
|
| 2021-05-28 |
股东大会：
将于2021-07-27召开股东大会
|
| 2019-11-18 |
除权日：
美东时间 2019-11-27 每股派息0.50美元
|
| 2019-05-22 |
除权日：
美东时间 2019-06-06 每股派息0.46美元
|
| 2018-11-13 |
除权日：
美东时间 2018-11-21 每股派息0.55美元
|
| 2018-07-25 |
财报披露：
美东时间 2018-07-25 盘前发布财报
|
| 2018-05-16 |
除权日：
美东时间 2018-06-07 每股派息1.19美元
|
| 2018-04-16 |
股东大会：
将于2018-07-27召开股东大会
会议内容 ▼▲
- 1.Further to the announcement by the Company on 15 May 2018, Margherita Della Valle was appointed as Group Chief Financial Officer and Director of the Company, succeeding Nick Read, who was today appointed as Group Chief Executive-Designate until he succeeds Vittorio Colao as Group Chief Executive Officer on 1 October 2018.
2.As announced on 16 April 2018, Dr Mathias Dapfner stood down as a Director of the Company from the close of business of the Annual General Meeting.
3.As a result of Dr Dapfner’s decision to stand down from the Board and as announced on 11 May 2018, Michel Demaré has today been appointed as a member of the Remuneration Committee.
|
| 2018-04-16 |
股东大会：
将于2018-07-27召开股东大会
会议内容 ▼▲
- 1.Further to the announcement by the Company on 15 May 2018, Margherita Della Valle was appointed as Group Chief Financial Officer and Director of the Company, succeeding Nick Read, who was today appointed as Group Chief Executive-Designate until he succeeds Vittorio Colao as Group Chief Executive Officer on 1 October 2018.
2.As announced on 16 April 2018, Dr Mathias Dapfner stood down as a Director of the Company from the close of business of the Annual General Meeting.
3.As a result of Dr Dapfner’s decision to stand down from the Board and as announced on 11 May 2018, Michel Demaré has today been appointed as a member of the Remuneration Committee.
|
| 2018-02-01 |
财报披露：
美东时间 2018-02-01 盘前发布财报
|
| 2017-11-14 |
除权日：
美东时间 2017-11-22 每股派息0.60美元
|
| 2017-07-31 |
股东大会：
将于2017-07-28召开股东大会
会议内容 ▼▲
- 1.To receive the Company’s accounts, the strategic report and reports of the Directors and the auditor for the year ended 31 March 2017
2.To re-elect Gerard Kleisterlee as a Director
3.To re-elect Vittorio Colao as a Director
4.To re-elect Nick Read as a Director
5.To re-elect Sir Crispin Davis as a Director
6.To re-elect Dr Mathias Dopfner as a Director
7.To re-elect Dame Clara Furse as a Director
8.To re-elect Valerie Gooding as a Director
9.To re-elect Renee James as a Director
10.To re-elect Samuel Jonah as a Director
11.To elect Maria Amparo Moraleda Martinez as a Director in accordance with the Company’s Articles of Association
12.To re-elect David Nish as a Director
13.To declare a final dividend of 10.03 eurocents per ordinary share for the year ended 31 March 2017
14.To approve the Directors’ Remuneration Policy contained in the Remuneration Report of the Board for the year ended 31 March 2017
15.To approve the Annual Report on Remuneration contained in the Remuneration Report of the Board for the year ended 31 March 2017
16.To reappoint PricewaterhouseCoopers LLP as the Company’s auditor until the end of the next general meeting at which accounts are laid before the Company
17.To authorise the Audit and Risk Committee to determine the remuneration of the Auditor
18.To authorise the Directors to allot shares
19.To authorise the Directors to dis-apply pre-emption rights
20.To authorise the Directors to dis-apply pre-emption rights up to a further 5% for the purposes of financing an acquisition or other capital investment
21.To authorise the Company to purchase its own shares
22.To authorise political donations and expenditure
23.To authorise the Directors to call general meetings (other than annual general meetings) on a minimum of 14 clear days’ notice
|
| 2017-07-31 |
股东大会：
将于2017-07-28召开股东大会
会议内容 ▼▲
- 1.To receive the Company’s accounts, the strategic report and reports of the Directors and the auditor for the year ended 31 March 2017
2.To re-elect Gerard Kleisterlee as a Director
3.To re-elect Vittorio Colao as a Director
4.To re-elect Nick Read as a Director
5.To re-elect Sir Crispin Davis as a Director
6.To re-elect Dr Mathias Dopfner as a Director
7.To re-elect Dame Clara Furse as a Director
8.To re-elect Valerie Gooding as a Director
9.To re-elect Renee James as a Director
10.To re-elect Samuel Jonah as a Director
11.To elect Maria Amparo Moraleda Martinez as a Director in accordance with the Company’s Articles of Association
12.To re-elect David Nish as a Director
13.To declare a final dividend of 10.03 eurocents per ordinary share for the year ended 31 March 2017
14.To approve the Directors’ Remuneration Policy contained in the Remuneration Report of the Board for the year ended 31 March 2017
15.To approve the Annual Report on Remuneration contained in the Remuneration Report of the Board for the year ended 31 March 2017
16.To reappoint PricewaterhouseCoopers LLP as the Company’s auditor until the end of the next general meeting at which accounts are laid before the Company
17.To authorise the Audit and Risk Committee to determine the remuneration of the Auditor
18.To authorise the Directors to allot shares
19.To authorise the Directors to dis-apply pre-emption rights
20.To authorise the Directors to dis-apply pre-emption rights up to a further 5% for the purposes of financing an acquisition or other capital investment
21.To authorise the Company to purchase its own shares
22.To authorise political donations and expenditure
23.To authorise the Directors to call general meetings (other than annual general meetings) on a minimum of 14 clear days’ notice
|
| 2016-11-17 |
除权日：
美东时间 2016-11-22 每股派息0.51美元
|
| 2016-05-17 |
除权日：
美东时间 2016-06-08 每股派息1.02美元
|
| 2015-11-10 |
除权日：
美东时间 2015-11-18 每股派息0.52美元
|
| 2015-09-04 |
股东大会：
将于2015-07-28召开股东大会
|
| 2015-09-04 |
股东大会：
将于2015-07-28召开股东大会
|
| 2013-11-12 |
除权日：
美东时间 2013-11-20 每股派息0.59美元
|
| 2012-11-13 |
除权日：
美东时间 2012-11-20 每股派息0.52美元
|
| 2011-11-09 |
除权日：
美东时间 2011-11-16 每股派息1.09美元
|